GOVX (Geovax Labs) FFO


GOVX Geovax Labs Inc GOVX
22 GF Score
Price $1.32
! 3 Warning Signs
View Full Analysis

What is Geovax Labs FFO?

FFO (Funds from operations) only applies to REITs.

GOVX
22GF Score
Geovax Labs Inc GOVX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Geovax Labs Business Description

Address 1955 Lake Park Drive, Suite 300, Smyrna, GA, USA, 30080
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
22GF Score

Get the complete analysis for GOVX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.32
Price